A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Once-weekly efsitora vs once-daily degludec was associated with comparable glycemic control outcomes and improved ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...